Basic Information | Post buying leads | Suppliers |
Name |
Zinc insulin |
EINECS | N/A |
CAS No. | 8049-62-5 | Density | N/A |
PSA | N/A | LogP | N/A |
Solubility | N/A | Melting Point |
N/A |
Formula | N/A | Boiling Point | N/A |
Molecular Weight | 0 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | An experimental teratogen. Questionable carcinogen with experimental carcinogenic data. When heated to decomposition it emits toxic fumes of ZnO. See also INSULIN. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Caninsulin;Extended insulin zinc suspension; HOE 21PH; IZSAB; Iletin U 40; Insulin NovoLente MC; Insulin Novo Semilente MC; Insulin lente; Insulin semilente; Insulinultralente; Insulin zinc complex; Insulin zinc suspension; Lente iletin; Lenteinsulin; Monotard; Monotard HM; Novolin U; Pentex Zn salt; Prompt insulin zincsuspension; Semilente iletin; Semilente insulin; Semitard MC; Ultralenteinsulin; Ultratard; Zinc insulin |
EINECS of Zinc insulin (CAS NO.8049-62-5): 232-469-4
1. | ims-wmn TDLo:2100 mg/kg/9.5Y I | JAMAAP JAMA, Journal of the American Medical Association. 233 (1975),985. | ||
2. | scu-mus LDLo:37 mg/kg | DRUGAY Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. 6 (1982),84. | ||
3. | scu-rbt LDLo:75 mg/kg | DRUGAY Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. 6 (1982),84. |
Zinc and its compounds are on the Community Right-To-Know List.
An experimental teratogen. Questionable carcinogen with experimental carcinogenic data. When heated to decomposition it emits toxic fumes of ZnO. See also INSULIN.
Zinc insulin , its cas register number is 8049-62-5. It also can be called Insulin, lente ; Lente insulin ; Insulin, isophane [INN] ; and Insulin zinc .